Status:
NOT_YET_RECRUITING
Evaluation of the LUSHA Digital Application for Children With ADHD - Feasibility Study
Lead Sponsor:
University Hospital, Grenoble
Collaborating Sponsors:
DYGIE (France)
Conditions:
Attention Deficit Disorder With or Without Hyperactivity (ADHD)
Children
Eligibility:
All Genders
7-12 years
Phase:
NA
Brief Summary
Attention Deficit Disorder with or without Hyperactivity (ADHD) is a neurodevelopmental disorder characterized by a triad of symptoms combining inattention, hyperactivity, and/or impulsivity. It cause...
Eligibility Criteria
Inclusion
- Children aged 7-12 years
- Already diagnosed with ADHD
- Consulting in a participating center
- No indication of treatment changes (no treatment or medication stabilized for 2 months)
- Family with a smartphone compatible with downloading the app
- Non-opposition of both parents and the child (if possible)
Exclusion
- Parent under guardianship or deprived of liberty
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07204873
Start Date
October 1 2025
End Date
July 1 2027
Last Update
October 2 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital, Grenoble
Grenoble, France
2
University Hospital, Montpellier
Montpellier, France